Your session is about to expire
← Back to Search
Procedure
Disposable vs Reusable Ureteroscopes for Kidney Stones
N/A
Waitlist Available
Led By Ben H Chew, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 8 months
Awards & highlights
Study Summary
This trial is comparing two types of ureteroscopes to see if one is better than the other at treating kidney stones.
Who is the study for?
This trial is for adults 19 years or older who need ureteroscopy and laser lithotripsy for kidney stones. The stone size must be between 5 mm to 20 mm, or if multiple stones are present, their total size shouldn't exceed 20 mm. Pregnant individuals, patients with nephrocalcinosis, minors under 18, or anyone deemed unsuitable by the investigator cannot participate.Check my eligibility
What is being tested?
The study is comparing single-use flexible digital ureteroscopes against reusable ones during procedures to treat kidney stones. It aims to determine which type of scope performs better in order to guide future purchasing decisions for medical institutions.See study design
What are the potential side effects?
While the trial description does not specify side effects related to the use of different scopes, typical risks may include discomfort during the procedure, urinary tract infections, bleeding around the kidney stone site, and possible injury to the urethra or bladder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 8 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 8 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Stone-free status
Secondary outcome measures
Case completion with one scope
Maintenance and Repair
Scope optics (visual quality of the image provided by the scope)
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: single-use flexible digital ureteroscope (LithoVue)Experimental Treatment1 Intervention
Disposable ureteroscope being tested.
Group II: Reusable UreteroscopeActive Control1 Intervention
Standard ureteroscope.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,976 Total Patients Enrolled
11 Trials studying Kidney Stones
4,602 Patients Enrolled for Kidney Stones
Boston Scientific CorporationIndustry Sponsor
719 Previous Clinical Trials
933,030 Total Patients Enrolled
2 Trials studying Kidney Stones
20 Patients Enrolled for Kidney Stones
Ben H Chew, MDPrincipal InvestigatorUniversity of British Columbia, Associate Professor
3 Previous Clinical Trials
515 Total Patients Enrolled
1 Trials studying Kidney Stones
9 Patients Enrolled for Kidney Stones
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Reusable Ureteroscope
- Group 2: single-use flexible digital ureteroscope (LithoVue)
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies for participants in this trial?
"According to clinicaltrials.gov, this particular investigation is not currently recruiting participants - it was first posted on December 1st 2017 and last updated May 16th 2022. Nevertheless, 88 other medical trials are still actively enrolling patients at present."
Answered by AI
Share this study with friends
Copy Link
Messenger